Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-22

Clinical Trial Update: RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults [Phase 2]

View source ↗

Summary

Phase II trial update for the RSV-MVA-BN vaccine in adults aged 55 and older; trial completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSV-MVA-BN (RSV-MVA-BN vaccine)

Snippet

Sponsor: Bavarian Nordic | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED | Results posted: 2020-09-22